ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing’s syndrome

BACKGROUND: Cushing’s syndrome in humans shares many similarities with its counterpart in dogs in terms of etiology (pituitary versus adrenal causes), clinical signs, and pathophysiologic sequelae. In both species, treatment of pituitary- and adrenal-dependent disease is met with limitations. ATR-10...

Descripción completa

Detalles Bibliográficos
Autores principales: Langlois, Daniel K., Fritz, Michele C., Schall, William D., Bari Olivier, N., Smedley, Rebecca C., Pearson, Paul G., Bailie, Marc B., Hunt, Stephen W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932779/
https://www.ncbi.nlm.nih.gov/pubmed/29720169
http://dx.doi.org/10.1186/s12902-018-0251-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932779/
https://www.ncbi.nlm.nih.gov/pubmed/29720169
http://dx.doi.org/10.1186/s12902-018-0251-5

Ejemplares similares